Literature DB >> 33156582

Racial Disproportionality in Covid Clinical Trials. Reply.

Daniel B Chastain1, Andrés F Henao-Martínez2, Henry N Young3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33156582     DOI： 10.1056/NEJMc2029374

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Exploring ethnic representativeness in diabetes clinical trial enrolment from 2000 to 2020: a chronological survey.

Authors:  Guowei Li; Jingyi Zhang; Harriette G C Van Spall; Pamela S Douglas; Yaoyao Wang; Xin Sun; Lehana Thabane
Journal:  Diabetologia       Date:  2022-06-16       Impact factor: 10.460

2.  Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial.

Authors:  Christine Johnston; Elizabeth R Brown; Jenell Stewart; Helen C Stankiewicz Karita; Patricia J Kissinger; John Dwyer; Sybil Hosek; Temitope Oyedele; Michael K Paasche-Orlow; Kristopher Paolino; Kate B Heller; Hannah Leingang; Harald S Haugen; Tracy Q Dong; Anna Bershteyn; Arun R Sridhar; Jeanne Poole; Peter A Noseworthy; Michael J Ackerman; Susan Morrison; Alexander L Greninger; Meei-Li Huang; Keith R Jerome; Mark H Wener; Anna Wald; Joshua T Schiffer; Connie Celum; Helen Y Chu; Ruanne V Barnabas; Jared M Baeten
Journal:  EClinicalMedicine       Date:  2021-02-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.